Trial Profile
Sildenafil for COPD-associated Pulmonary Hypertension. A Randomized Double Blinded Placebo Controlled Study.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2022
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary)
- Indications Chronic obstructive pulmonary disease; Pulmonary hypertension
- Focus Therapeutic Use
- 03 Aug 2022 Status changed to discontinued.
- 24 Sep 2016 New trial record